Literature DB >> 5323684

Studies with allopurinol (HPP) in patients with tophaceous gout.

C J Smyth.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 5323684     DOI: 10.1002/art.1780080457

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  6 in total

Review 1.  Gout treatment: what is evidence-based and how do we determine and promote optimized clinical care?

Authors:  Ted R Mikuls; Kenneth G Saag
Journal:  Curr Rheumatol Rep       Date:  2005-06       Impact factor: 4.592

2.  Pyrazolidines in the treatment of gout.

Authors:  W C Kuzell
Journal:  Can Med Assoc J       Date:  1968-11-30       Impact factor: 8.262

3.  Allopurinol in the treatment of uraemic patients with gout.

Authors:  J D Wilson; H A Simmonds; J D North
Journal:  Ann Rheum Dis       Date:  1967-03       Impact factor: 19.103

4.  Treatment of gout by reduction of uric acid production.

Authors:  G D Kersley
Journal:  Ann Rheum Dis       Date:  1966-07       Impact factor: 19.103

5.  Allopurinol in treatment of gout.

Authors:  J T Scott; A P Hall; R Grahame
Journal:  Br Med J       Date:  1966-08-06

6.  The treatment of gout and disorders of uric acid metabolism with allopurinol.

Authors:  M A Ogryzlo; M B Urowitz; H M Weber; J B Houpt
Journal:  Can Med Assoc J       Date:  1966-11-26       Impact factor: 8.262

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.